These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 21261670)

  • 1. Night-time intra-oesophageal bile and acid: a comparison between gastro-oesophageal reflux disease patients who failed and those who were treated successfully with a proton pump inhibitor.
    Hershcovici T; Jha LK; Cui H; Powers J; Fass R
    Aliment Pharmacol Ther; 2011 Apr; 33(7):837-44. PubMed ID: 21261670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Night-time intra-oesophageal bile and acid exposure in GERD patients failing PPI therapy.
    Leontiadis GI; Tse F
    Aliment Pharmacol Ther; 2011 May; 33(9):1068-9; author reply 1069. PubMed ID: 21453322
    [No Abstract]   [Full Text] [Related]  

  • 3. Oesophageal and gastric pH profiles in patients with gastro-oesophageal reflux disease and Barrett's oesophagus treated with proton pump inhibitors.
    Gerson LB; Boparai V; Ullah N; Triadafilopoulos G
    Aliment Pharmacol Ther; 2004 Sep; 20(6):637-43. PubMed ID: 15352912
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review article: physiologic and clinical effects of proton pump inhibitors on non-acidic and acidic gastro-oesophageal reflux.
    Miner PB
    Aliment Pharmacol Ther; 2006 Mar; 23 Suppl 1():25-32. PubMed ID: 16483267
    [TBL] [Abstract][Full Text] [Related]  

  • 5. On-demand requirements of patients with endoscopy-negative gastro-oesophageal reflux disease: H2-blocker vs. proton pump inhibitor.
    Juul-Hansen P; Rydning A
    Aliment Pharmacol Ther; 2009 Jan; 29(2):207-12. PubMed ID: 19006541
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gastroesophageal reflux disease poorly responsive to single-dose proton pump inhibitors in patients without Barrett's esophagus: acid reflux, bile reflux, or both?
    Tack J; Koek G; Demedts I; Sifrim D; Janssens J
    Am J Gastroenterol; 2004 Jun; 99(6):981-8. PubMed ID: 15180713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the degree of duodenogastroesophageal reflux and acid reflux between patients who failed to respond and those who were successfully treated with a proton pump inhibitor once daily.
    Gasiorowska A; Navarro-Rodriguez T; Wendel C; Krupinski E; Perry ZH; Koenig K; Moty B; Powers J; Fass R
    Am J Gastroenterol; 2009 Aug; 104(8):2005-13. PubMed ID: 19491829
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Randomised clinical trial: effects of monotherapy with ADX10059, a mGluR5 inhibitor, on symptoms and reflux events in patients with gastro-oesophageal reflux disease.
    Zerbib F; Bruley des Varannes S; Roman S; Tutuian R; Galmiche JP; Mion F; Tack J; Malfertheiner P; Keywood C
    Aliment Pharmacol Ther; 2011 Apr; 33(8):911-21. PubMed ID: 21320138
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Weakly acidic refluxes have a major role in the pathogenesis of proton pump inhibitor-resistant reflux oesophagitis.
    Frazzoni M; Conigliaro R; Melotti G
    Aliment Pharmacol Ther; 2011 Mar; 33(5):601-6. PubMed ID: 21198705
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Review article: acidity and volume of the refluxate in the genesis of gastro-oesophageal reflux disease symptoms.
    Sifrim D; Mittal R; Fass R; Smout A; Castell D; Tack J; Gregersen H
    Aliment Pharmacol Ther; 2007 May; 25(9):1003-17. PubMed ID: 17439501
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oesophageal acid hypersensitivity is not a contraindication to Nissen fundoplication.
    Broeders JA; Draaisma WA; Bredenoord AJ; de Vries DR; Rijnhart-de Jong HG; Smout AJ; Gooszen HG
    Br J Surg; 2009 Sep; 96(9):1023-30. PubMed ID: 19672931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Determinants of gastro-oesophageal reflux perception in patients with persistent symptoms despite proton pump inhibitors.
    Zerbib F; Duriez A; Roman S; Capdepont M; Mion F
    Gut; 2008 Feb; 57(2):156-60. PubMed ID: 17951358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nocturnal gastric acid breakthrough is not associated with night-time gastroesophageal reflux in GERD patients.
    Weigt J; Kandulski A; Büsch F; Malfertheiner P
    Dig Dis; 2009; 27(1):68-73. PubMed ID: 19439964
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical trial: acupuncture vs. doubling the proton pump inhibitor dose in refractory heartburn.
    Dickman R; Schiff E; Holland A; Wright C; Sarela SR; Han B; Fass R
    Aliment Pharmacol Ther; 2007 Nov; 26(10):1333-44. PubMed ID: 17875198
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The 12-month safety profile of dexlansoprazole, a proton pump inhibitor with a dual delayed release formulation, in patients with gastro-oesophageal reflux disease.
    Dabholkar AH; Han C; Paris MM; Perez MC; Atkinson SN; Peura DA
    Aliment Pharmacol Ther; 2011 Feb; 33(3):366-77. PubMed ID: 21118280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Night acid "bursting": treatment of patients with gastroesophageal reflux disease].
    Vasil'ev IuV; Beliaeva VS
    Eksp Klin Gastroenterol; 2007; (3):83-91. PubMed ID: 17937011
    [No Abstract]   [Full Text] [Related]  

  • 17. [Therapy resistance of gastro-oesophageal reflux symptoms: acid reflux, non-acid reflux or no reflux].
    Bredenoord AJ; Smout AJ
    Ned Tijdschr Geneeskd; 2008 Nov; 152(47):2548-52. PubMed ID: 19174935
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gastro-oesophageal reflux and gastric aspiration in lung transplant patients with or without chronic rejection.
    Blondeau K; Mertens V; Vanaudenaerde BA; Verleden GM; Van Raemdonck DE; Sifrim D; Dupont LJ
    Eur Respir J; 2008 Apr; 31(4):707-13. PubMed ID: 18057058
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical trial: Radiofrequency energy delivery in proton pump inhibitor-dependent gastro-oesophageal reflux disease patients.
    Coron E; Sebille V; Cadiot G; Zerbib F; Ducrotte P; Ducrot F; Pouderoux P; Arts J; Le Rhun M; Piche T; Bruley des Varannes S; Galmiche JP;
    Aliment Pharmacol Ther; 2008 Nov; 28(9):1147-58. PubMed ID: 18616516
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of symptom-reflux association analysis on long-term outcome after Nissen fundoplication.
    Broeders JA; Draaisma WA; Bredenoord AJ; Smout AJ; Broeders IA; Gooszen HG
    Br J Surg; 2011 Feb; 98(2):247-54. PubMed ID: 20960456
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.